Provided by Tiger Fintech (Singapore) Pte. Ltd.

Insmed

70.68
-2.9400-3.99%
Post-market: 70.680.00000.00%19:51 EDT
Volume:1.92M
Turnover:137.19M
Market Cap:12.87B
PE:-12.01
High:74.32
Open:73.97
Low:70.57
Close:73.62
Loading ...

Promising Phase 2 Data and Market Potential Drive Buy Rating for Insmed’s TPIP in PAH Treatment

TIPRANKS
·
Yesterday

Insmed Inc. Completes Redemption of Convertible Senior Notes Due 2028

Reuters
·
07 Jun

Michael Alexander Smith, Chief Legal Officer, Reports Disposal of Insmed Inc. Common Shares

Reuters
·
07 Jun

Chief Medical Officer Martina Flammer Reports Disposal of Insmed Inc. Common Shares

Reuters
·
05 Jun

Sara Bonstein, CFO of Insmed Inc., Reports Disposal of Common Shares

Reuters
·
05 Jun

Nicole Schaeffer Orlov, Chief People Strategy Officer, Reports Disposal of Common Shares of Insmed Inc

Reuters
·
05 Jun

William Lewis, Chair and CEO of Insmed Inc., Reports Disposal of Common Shares

Reuters
·
05 Jun

Insmed Inc. Announces Inducement Grants for 150 New Employees Under 2025 Compensation Plan

Reuters
·
05 Jun

Insmed Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
05 Jun

Leerink Partners Keeps Their Buy Rating on Insmed (INSM)

TIPRANKS
·
04 Jun

Mizuho updates U.S. top picks: Adds CVS Health, PayPal and Oracle

Investing.com
·
04 Jun

Chief Legal Officer Michael Alexander Smith Reports Disposal of Common Shares of Insmed Inc

Reuters
·
04 Jun

Insmed Inc. to Present at Goldman Sachs Annual Global Healthcare Conference

Reuters
·
28 May

Director Clarissa Desjardins Reports Acquisition of Insmed Inc. Common Shares

Reuters
·
23 May

Insmed Inc. Chair and CEO William Lewis Reports Disposal of Common Shares

Reuters
·
23 May

Insmed Says Brensocatib Showed Consistent Efficacy in Non-Cystic Fibrosis Bronchiectasis

MT Newswires Live
·
22 May

Insmed’s brensocatib shows efficacy and safety in fibrosis bronchiectasis trial

TIPRANKS
·
22 May

Insmed Inc. Reveals Promising Brensocatib Results Across Key Subgroups in Landmark ASPEN Study at ATS 2025 Conference

Reuters
·
22 May

Guggenheim Keeps Their Buy Rating on Insmed (INSM)

TIPRANKS
·
20 May

Chief Medical Officer Martina Flammer Reports Disposal of Insmed Inc. Common Shares

Reuters
·
20 May